Skip to main content
AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.36%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.36%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.06%ABBV+0.94%ASMLa+0.68%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%HD+0.72%3988.HK-1.13%BAC-3.15%1816.HK+3.45%GE-2.87%0857.HK-0.49%ORCL-8.48%UNH+2.85%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L+0.29%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.58%ORp+0.16%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.17%ETHUSD+71.01%USDTUSD+0.13%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.20%ZECUSDT+1.87%XMRUSDT-0.45%DOGEUSD+69.80%LINKUSD+2.16%XLMUSD-0.56%BCHUSDT-0.25%LTCUSD+68.40%UNIUSD-0.80%TONUSD+79.92%SUIUSD+1.58%HBARUSDT-0.11%TAOUSDT+2.71%AAVEUSD+1.51%ONDOUSDT+1.09%DOTUSDT+1.15%ICPUSDT+1.84%WLDUSDT+2.44%ARBUSDT+2.38%ATOMUSDT+1.98%INJUSDT+4.96%STXUSDT+4.58%PYTHUSDT+3.03%TIAUSDT+3.05%FETUSDT-0.17%SEIUSDT+0.59%JUPUSDT+1.87%GRTUSDT+0.73%OPUSDT+1.55%IOTAUSDT+1.72%POLUSDT-0.05%WIFUSDT+2.36%AXSUSDT+0.01%EOSUSDT+0.68%IMXUSDT+0.09%FARTCOINUSDT+1.22%GALAUSDT+2.69%DYDXUSDT+0.53%ORDIUSDT+2.36%NOTUSDT+1.19%RONINUSDT+1.91%AAPL+0.69%MSFT+0.96%GOOGL-2.70%NVDA+3.63%AMZN+1.69%SPCX-7.69%TSM-9.36%AVGO-12.19%META+1.21%TSLA+1.46%LLY-0.30%WMT+1.52%JPM-2.98%BRK-B-0.36%V-0.09%SKHY-13.11%AMD-13.25%MU+2.48%XOM+0.67%JNJ+1.25%MA-0.06%ABBV+0.94%ASMLa+0.68%COST+0.76%1398.HK+0.25%KO+0.94%CVX+0.91%0700.HK-1.26%PG+0.91%CSCO-4.29%0939.HK0.00%HD+0.72%3988.HK-1.13%BAC-3.15%1816.HK+3.45%GE-2.87%0857.HK-0.49%ORCL-8.48%UNH+2.85%1288.HK-0.45%PM-1.26%0005.HK-3.08%NVS-0.50%HSBA.L+0.29%INTC-7.97%AZN-0.60%MS-5.32%RTX-1.58%ORp+0.16%TMO-2.79%GBPTRY+0.41%GBPHKD+0.32%GBPMXN-0.28%USDILS+0.16%USDCOP-0.04%GBPSGD0.00%PLNJPY0.00%GBPZAR0.00%USDZAR0.00%USDPLN0.00%EURNZD0.00%AUDCHF0.00%EURSEK0.00%GBPUSD0.00%GBPCHF0.00%USDDKK0.00%USDHKD0.00%CADJPY0.00%GBPCAD0.00%NZDCAD0.00%GBPNZD0.00%GBPAUD0.00%EURCAD0.00%EURJPY0.00%EURNOK0.00%EURUSD0.00%CADCHF0.00%NZDCHF0.00%NZDSGD0.00%EURCZK0.00%NOKJPY0.00%AUDCAD0.00%CHFSGD0.00%SGDJPY0.00%AUDSGD0.00%NZDUSD0.00%GBPJPY0.00%EURGBP0.00%AUDNZD0.00%AUDJPY0.00%AUDUSD0.00%USDJPY0.00%USDCNH0.00%EURCHF0.00%USDMXN0.00%USDNOK0.00%USDTHB0.00%USDTRY0.00%USDSEK0.00%USDCAD0.00%USDCHF0.00%EURHKD0.00%EURAUD0.00%AUDNOK0.00%EURCNH0.00%EURZAR0.00%EURSGD0.00%AUDDKK0.00%CHFSEK0.00%USDSGD0.00%EURPLN0.00%NZDJPY0.00%CHFJPY0.00%CHFNOK0.00%EURDKK0.00%NZDMXN0.00%GAGUSD0.00%W10.00%XAGUSD0.00%HG10.00%S10.00%C10.00%XNGUSD0.00%USOIL0.00%XAUUSD0.00%SUGAR0.00%COTTON0.00%COFFEE0.00%BTCUSD+1.17%ETHUSD+71.01%USDTUSD+0.13%XRPUSD+61.26%SOLUSD+68.72%TRXUSDT+0.20%ZECUSDT+1.87%XMRUSDT-0.45%DOGEUSD+69.80%LINKUSD+2.16%XLMUSD-0.56%BCHUSDT-0.25%LTCUSD+68.40%UNIUSD-0.80%TONUSD+79.92%SUIUSD+1.58%HBARUSDT-0.11%TAOUSDT+2.71%AAVEUSD+1.51%ONDOUSDT+1.09%DOTUSDT+1.15%ICPUSDT+1.84%WLDUSDT+2.44%ARBUSDT+2.38%ATOMUSDT+1.98%INJUSDT+4.96%STXUSDT+4.58%PYTHUSDT+3.03%TIAUSDT+3.05%FETUSDT-0.17%SEIUSDT+0.59%JUPUSDT+1.87%GRTUSDT+0.73%OPUSDT+1.55%IOTAUSDT+1.72%POLUSDT-0.05%WIFUSDT+2.36%AXSUSDT+0.01%EOSUSDT+0.68%IMXUSDT+0.09%FARTCOINUSDT+1.22%GALAUSDT+2.69%DYDXUSDT+0.53%ORDIUSDT+2.36%NOTUSDT+1.19%RONINUSDT+1.91%
QD

Quest Diagnostics Incorporated (DGX)

NYSE • Healthcare

$258.27
-$0.81 (-0.3%)
Market closed

November 20, 2026 at 21:00 UTC

Open$262
Day Range$257.56 - $262.96
Avg. Volume (3M)950.9K
Market Cap$28.4B
P/E Ratio25.4
52 Week Range
$171.18$263.19
Next EarningsIn 79 daysFeb 9, 2027

Interactive Chart

14:05:19 UTC

Metrics Over Time

Where the Money Goes

Q3 2026
Revenueeverything earned$3B100%
Gross Profitminus cost of goods$1B34%
Operating Incomeminus R&D and overhead$479M15%
Net Incomeminus taxes and the rest$312M10%

In plain terms: out of every $100 in revenue, Quest Diagnostics Incorporated keeps $10 as net profit.

Fundamentals & Financials

Revenue (TTM)
$11.8B
Net Income (TTM)
$1.1B
EPS (TTM)
$10.18
ROA (TTM)
6.56%
Current Ratio
1.7
Dividend Yield
0.37%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+5.5%Q2 2026$2.5
+10.6%Q3 2026$3.12
+4.5%Q4 2026$3
Next

Feb 9

in 79 daysQ1 2027

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q4 2026
Beat +4.5%

Quest Diagnostics topped consensus on both revenue and earnings in the third fiscal quarter of 2026, based on preliminary results reported October 22, 2026, with revenue up 10.0% to about $3.1 billion and adjusted EPS of $3.00 topping the $2.87 estimate (+4.5%). On the top line, revenue of $3.097 billion topped the $3.052 billion estimate (+1.5%) as the quarter reflected continued demand across its diagnostic information services footprint, including routine and advanced clinical testing and anatomic pathology. Profitability came through at a gross margin of ~34% and an operating margin of roughly 16%, translating to about $312.0 million of net income, up 27.3% from roughly $245.0 million a year ago. Cash generation was positive, with operating cash flow of about $740.0 million, and Quest returned capital through roughly $150.0 million of share repurchases and about $95.0 million in dividends during the period. For the next period, consensus calls for EPS of $2.68 on revenue of $3.034 billion.

View full earnings history

About Quest Diagnostics Incorporated

Quest Diagnostics Incorporated (NYSE: DGX) provides diagnostic information services, risk assessment services, and healthcare information technology in the medical diagnostics and research business. The company generated $11.0 billion of revenue in FY2025. Its work spans routine and advanced clinical testing, anatomic pathology, insurance-focused assessments, and software used by healthcare organizations and clinicians.

Name
Quest Diagnostics Incorporated
CEO
James E. Davis
Industry
Healthcare
Year Founded
1967
Employees
57,000

Today's Snapshot

AI-generated

DGX closed slightly lower at 258.28, in line with a flat sector. Shares changed hands at about half as much again as its usual level. Quest Diagnostics raised its earnings outlook as physician and hospital revenue strengthened.

Trading Volume

Above 10d avg 944.9K

1.3M

vs S&P 500 Today

Strong Outperformance

+3.18%

Updated: November 20, 2026 at 21:24 UTC

Technical Indicators

5 Buy3 Neutral0 Sell
DGX registers a Buy stance with the stock trading around 258.28, where short-term momentum is favorable while trend strength remains muted. Momentum measures are constructive and the MACD shows a positive level, meanwhile most medium- and long-term moving averages sit below the current price, which supports the bias despite a 10-day simple moving average just above. Volatility is moderate and average true range is modest, while on-balance volume is negative, tempering enthusiasm. The classic pivot sits essentially level with the market. Technical takeaway: modest bullish momentum with weak trend strength—lean buy but cautious given mixed volume and trend readings.
All signals
  • EMA (5 indicators)$219.05 - $257.83
    Buy
  • RSI (14)60.76
    Neutral
  • Stochastic %K (14, 3, 3)77.59
    Neutral
  • MACD Level (12, 26)5.05
    Neutral
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.